AFP – One of Myanmar’s ethnic groups pledged on 11 August to block elections in areas it controls, rejecting polls the military government has touted as a way of ending the nation’s civil unrest.
Myanmar Ethnic Group Vows to Block Elections in its Enclave
Dr. Bronner’s Boosts Marketplace Revenue by 55% with Pattern
Strategic overhaul delivers stronger brand control and a 38% uplift in units sold
MELBOURNE, Australia, Aug. 12, 2025 /PRNewswire/ — Leading global ecommerce and marketplace accelerator, Pattern, today announced it has supported iconic organic soap and personal care brand Dr. Bronner’s to transform its marketplace performance in Australia, achieving a 55% growth in monthly revenue.
Photo Credit: Dr.Bronner’s
As the exclusive importer of Dr. Bronner’s Organic Body Care to Australia and New Zealand, Lateral Food Corporation has helped the brand build a loyal following locally. However, Dr. Bronner’s Amazon presence wasn’t reflecting the full strength of the brand. Product listings lacked structure, images were inconsistent, and pricing was frequently undermined by unauthorised resellers.
Pattern worked with Lateral Food Corporation to create a cleaner, more compelling brand experience on Amazon. The partnership aimed to sharpen Dr. Bronner’s presence, improve discoverability and put brand control back in the right hands.
“Dr Bronner’s. stands for integrity, in its products and how it shows up as a brand,” said Vanita Hutchinson, Sales Manager for Lateral Foods Corporation. “Dr Bronner’s. needed its Amazon storefront to reflect that; something that was structured, engaging and true to its values. Pattern helped make that happen.”
Pattern restructured Dr. Bronner’s catalogue, enhanced titles and SEO, and rolled out a refreshed storefront built around lifestyle content and intuitive navigation, including subpages by scent. These enhancements drove a 38% lift in average monthly units sold and a 55% increase in monthly revenue growth between January and May 2025, compared to the same period the year before. Storefront traffic nearly doubled, signalling a significant boost in customer interest and engagement.
“Dr. Bronner’s already had an incredible following and a strong product lineup,” explained Merline McGregor, Managing Director for Pattern Australia. “Our focus was on elevating the brand’s online presence to match that strength, refining the catalogue, optimising the experience and ultimately helping more customers connect with Dr. Bronner’s in an authentic way.”
Unauthorised sellers had previously flooded the listing space, creating inconsistent pricing and diminishing trust. Pattern’s tools helped the brand identify and respond to these sellers quickly, increasing Amazon Buy Box wins from 66% to 90%.
“Working with Pattern has made a real difference. They helped us protect the brand while opening up new opportunities to grow,” said Hutchinson. “Their team understood what matters to us and brought that to life in the way customers experience our products online.”
Advertising has played a crucial role in the brand’s marketplace turnaround. As of May, Pattern’s targeted campaign strategy now accounts for 93% of Dr. Bronner’s Amazon sales in Australia, driving sustained performance and standout results during key retail events.
“When brands combine great products with the right catalogue and promotional strategy, the results speak for themselves. By understanding when and how customers shop, we’ve been able to position Dr. Bronner’s front and centre during high-impact moments and turn that visibility into real growth,” McGregor concluded.
About Pattern Inc
Pattern is the category leader in global ecommerce and marketplace acceleration. It is the number one reseller on Amazon globally, selling over $3 billion of product each year into 60 countries. Since 2013, Pattern has profitably grown to over 2,000 employees operating from 24 global locations – including Melbourne, Sydney and the Gold Coast – to help leading brands achieve accelerated growth on D2C websites and global ecommerce marketplaces. Pattern is also present on Tmall, JD.com, eBay and other ecommerce marketplaces. We act as the authorised Amazon seller to more than 300 brands globally, buying their stock to sell on the marketplace and taking care of every aspect of their Amazon presence. For more information, visit https://au.pattern.com/
Nexusguard Partners with DIMA to Provide Advanced DDoS Protection Services in Bolivia
SINGAPORE, Aug. 12, 2025 /PRNewswire/ — Nexusguard, a global leader in DDoS protection has announced a strategic partnership with DIMA, a leading provider of IT solutions. This collaboration empowers organizations in Bolivia to safeguard their digital operations and ensure the continuity of their services with world-class cybersecurity solutions. The service is set to launch in August 2025.
The service includes a suite of advanced solutions from Nexusguard, tailored to meet the diverse needs of Bolivian businesses. These include:
- Application Protection, which safeguards websites and online applications from sophisticated DDoS attacks, ensuring uninterrupted access to critical digital services.
- Origin Protection, which defends backend infrastructure, such as servers and data centers, from volumetric and targeted DDoS attacks, keeping core systems operational.
- DNS Protection, which shields DNS servers from attacks, ensuring reliable access to services even during high-intensity threat events.
These solutions are designed to provide scalable, reliable, and proactive protection, giving businesses peace of mind while reducing operational risks in a rapidly evolving threat landscape.
By leveraging Nexusguard’s operational expense (opex) model, DIMA gains the flexibility to adopt and deliver advanced DDoS protection services without requiring significant upfront capital investments. This approach enables DIMA to offer cost-effective, world-class cybersecurity solutions that are accessible to businesses of all sizes.
“Partnering with Nexusguard marks a significant milestone for DIMA as we bring cutting-edge cybersecurity solutions to Bolivian businesses,” said Enrique Requena, CEO of DIMA. “This partnership enables us to bridge the gap between global innovation and local needs, ensuring that businesses of all sizes have access to advanced protection against increasingly sophisticated cyberthreats. By empowering organizations to safeguard their operations with ease and affordability, we’re helping them focus on growth, innovation, and long-term success in a rapidly changing digital landscape.”
“At Nexusguard, we are committed to empowering CSPs and partners globally with cutting-edge cybersecurity solutions to address the ever-evolving threat landscape,” said Andy Ng, CEO of Nexusguard. “Our partnership with DIMA exemplifies how we collaborate with leading service providers to bring world-class DDoS protection to local markets. By working together, we are equipping Bolivian businesses with the advanced tools they need to ensure operational resilience and confidently embrace digital transformation in a rapidly changing economy.”
DIMA’s commitment to innovation ensures that Bolivian organizations can now rely on the highest standards of cybersecurity. To support local businesses, DIMA and Nexusguard will host technical webinars to highlight the risks of DDoS attacks and demonstrate how their solutions safeguard critical operations.
For more information, visit www.dima.com.bo or contact:
Email: comercial@dima.com.bo
About DIMA
DIMA is a trusted technology partner with over four decades of experience delivering end-to-end IT infrastructure and services. Headquartered in Bolivia, the company specializes in integrating world-class hardware and software solutions with expert consulting to support the digital transformation of organizations across a wide range of industries. DIMA’s team of certified engineers ensures reliable execution at every stage of the project—from design and deployment to long-term support. Visit www.dima.com.bo for more information.
About Nexusguard
Established in 2008 and headquartered in Singapore, Nexusguard is a global leader in DDoS protection. Using proprietary Bastions technology and a global network of over 50 scrubbing centers, we provide comprehensive protection for networks, web applications, and DNS against malicious attacks. Trusted by 100+ CSPs, including top global providers, and protecting 50,000+ ASNs, we deliver scalable solutions ensuring service availability, operational continuity, and peace of mind. Nexusguard also enables CSPs to offer DDoS-protection-as-a-service, unlocking new revenue opportunities. Visit www.nexusguard.com for more information.
K-Food Captivates Hong Kong, the Culinary Heart of Asia
MAFRA and aT to Participate in the “2025 Hong Kong Food Expo” with a Unified Korea Pavilion
SEOUL, South Korea, Aug. 12, 2025 /PRNewswire/ — K-Food is accelerating the pace of its global expansion to elevate the international presence of the Korean food industry.
The Ministry of Agriculture, Food and Rural Affairs (MAFRA) and the Korea Agro-Fisheries & Food Trade Corporation (aT) announced that they will establish a Unified Korea Pavilion at the “2025 Hong Kong Food Expo,” held at the Hong Kong Convention and Exhibition Centre (HKCEC) from August 14 to 16, 2025. A total of 43 Korean food companies and local governments will participate, showcasing not only traditional foods but also a wide selection of new K-Food items in reflection of recent global consumer trends.
KOREA Pavilion @ Food Expo 2024
- K-Food Exhibition Featuring “Flavor” and “Convenience”
Centered around K-Food’s core image of health and “swicy” (sweet + spicy) flavor, the following product categories will be presented. In particular, products tailored to the preferences of Hong Kong consumers — who value convenience and quality — will be spotlighted.
Ginseng-based Products: Easy-to-consume processed products such as ginseng chips, ginseng pills, ginseng extract tea, wild ginseng liquor, and ginseng beer
K-Ready Meals: Instant products that require no cooking, including K-BBQ dumplings, kimchi dumplings, bibimbap, and ramen rice bowls
Spicy Dishes: Popular “swicy” ready-to-eat meals like tteokbokki (spicy rice cakes), stir-fried spicy baby octopus, and spicy glass noodles
Traditional Seasoning Products: Versatile sauces and side dishes such as multi-use gochujang, soy sauce, and fermented seafood for home-style meals
- From Buyer Consultations to Cooking Shows… Diverse On-site Programs
At the Korea Pavilion, B2B export consultation meetings will be held with prominent local buyers to actively support participating companies in helping them expand sales channels. During the event, interactive experiences will be available for visitors, including food performances, cooking shows, and tasting sessions. Chef Choi Jun-woo, honorary ambassador for Korean beef in Hong Kong, will demonstrate live cooking of 11 K-Food dishes, including Korean beef patties (tteokgalbi), tuna mayo gimbap, and rose tteokbokki, offering a rich tasting experience for attendees.
- “Hong Kong is a Strategic Market for K-Food Promotion”… aT
Kim Hyun-hoo, Branch director of aT’s Hong Kong office, said, “Hong Kong has high demand for premium food and strong interest in K-content.” Through this expo, we aim to showcase the unique strengths of Korean foods — especially ready meals and health products gaining global popularity — to local consumers and buyers.” He added, “We will use on-site consultations to establish a bridgehead for expanding into the Greater China market.”
CIMB Singapore unveils FX Online platform to empower SMEs with seamless cross-border transactions and guaranteed* best exchange rates in ASEAN
FX booking* made available digitally to all SMEs without having to open a business account.
SINGAPORE, Aug. 12, 2025 /PRNewswire/ — CIMB Singapore today unveils CIMB FX Online, a digital foreign exchange (FX) solution tailored to meet the cross-border trade payments needs of small and medium-sized enterprises (SMEs) at every stage of growth – from startups managing initial overseas vendor payments to mature businesses servicing international loans. CIMB FX Online also enables non-CIMB customers to instantly make a one-time FX booking without having to open a business account.
CIMB’s FX solution offers guaranteed best exchange rates for Singapore Dollar (SGD) to Malaysian Ringgit (MYR), Indonesian Rupiah (IDR) and Thailand Baht (THB), real-time FX pricing, and zero FX fees for the first transfer. The platform gives businesses full transparency of live exchange rates, enabling them to transact confidently without hidden fees. With simpler, faster and more cost-effective ways to managing finances, CIMB helps SMEs address common pain points like high costs, limited transparency and frequent delays in overseas payments.
“At CIMB, we are constantly innovating to meet the evolving needs of Singapore SMEs as they set their sights on overseas expansion. CIMB FX Online underscores our commitment to helping SMEs thrive across markets with a more transparent and cost-effective way to manage regional transactions. Backed by our strong digital capabilities, deep regional expertise, and customer-first approach, we remain dedicated to empowering SMEs with the tools they need to grow with confidence,” said Benjamin Tan, Head of Commercial & Transaction Banking, CIMB Singapore.
Existing CIMB Business Current Account holders can transact directly within the business banking portal, without needing to switch platforms. SMEs can trial FX Online for the first time without a CIMB business account, giving them an opportunity to have a first-hand experience of the service.
Key Features and Benefits*:
- Best exchange rates in ASEAN: Guaranteed best rates for SGD to MYR, IDR, and THB.
- Instant FX booking for non-customers: Enjoy a one-time FX booking without the need for a CIMB business account.
- Zero FX fees for first transfer: No hidden costs to help business owners reduce operating costs.
- Real-Time FX Rates: Full transparency of live exchange rates.
- Wide currency selection: Lock in preferred exchange rates for transactions in multiple currencies.
- Quick and secure platform: Seamless experience with an intuitive interface designed for easy navigation and secure transactions via Singpass MyInfo.
*Terms & conditions apply. For more information about CIMB FX Online, visit cimb.sg/fx-pr.
-END-
About CIMB
CIMB is one of ASEAN’s leading banking groups and Malaysia’s second largest financial services provider, by assets. Listed on Bursa Malaysia via CIMB Group Holdings Berhad, it had a market capitalisation of approximately RM75.2 billion as at 31 March 2025. It offers consumer banking, commercial banking, wholesale banking, transaction banking, Islamic banking and asset management products and services. Headquartered in Kuala Lumpur, the Group is present across ASEAN in Malaysia, Indonesia, Singapore, Thailand, Cambodia, Vietnam and Philippines. Singapore is one of its key markets with approximately 1,000 employees serving clients across consumer, commercial, wholesale and transaction banking products and services.
Beyond ASEAN, the Group has market presence in China, Hong Kong SAR and UK. CIMB has one of the most extensive retail branch networks in ASEAN with 592 branches and over 33,000 employees as at 31 March 2025. CIMB’s investment banking arm is one of the largest Asia Pacific-based investment banks, which together with its award-winning treasury & markets and corporate banking units comprise the Group’s leading wholesale banking franchise. CIMB is also the 92.5% shareholder of Bank CIMB Niaga in Indonesia, and 94.8% shareholder of CIMB Thai in Thailand.
Sustainability is a core pillar of CIMB’s Forward30 strategy and 2030 roadmap. The Group is guided by its Green, Social, Sustainable Impact Products and Services (“GSSIPS”) framework, an internal taxonomy designed to deliver impactful sustainable finance. Since launching its sustainable finance framework in 2021, CIMB has progressively raised its ambitions, increasing its initial RM30 billion target to RM100 billion for 2021–2024. The Group now targets RM300 billion in sustainable finance by 2030, reinforcing its commitment to enabling a lower-carbon and more inclusive economy across the region.
Fosun Pharma’s Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million
SHANGHAI, Aug. 12, 2025 /PRNewswire/ — On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics Inc.(Expedition) to grant Expedition the rights to develop, manufacture, and commercialize XH-S004, an orally administered dipeptidyl peptidase 1 (DPP-1) inhibitor independently developed by Fosun Pharma, in all regions globally except Chinese Mainland, Hong Kong SAR and Macau SAR. Fosun Pharma will retain the rights to develop, manufacture, and commercialize XH-S004 in Chinese Mainland, Hong Kong SAR and Macau SAR.
Under the agreement, Expedition will pay Fosun Pharma up to US$120 million including upfront payment and development milestone payments. In addition, based on the annual net sales of XH-004 in the licensed territories, Expedition will pay up to US$525 million in sales milestone payments as stipulated in the contract.
XH-S004 is a small molecule orally administered DPP-1 inhibitor independently developed by Fosun Pharma. It reduces inflammatory responses and blocks the infection cycle and airway structural damage by inhibiting DPP-1 and the neutrophil serine proteases activated by it. As of now, XH-S004 is in Phase II clinical trials in China for the treatment of non-cystic fibrosis bronchiectasis and in Phase 1b clinical trials for the treatment of chronic obstructive pulmonary disease(COPD). Currently, no small molecule orally administered inhibitors with the same mechanism of action have been approved for marketing worldwide.
“We are very pleased to have reached this collaboration with Expedition. XH-S004 is an innovative drug independently developed by Fosun Pharma for the treatment of respiratory system diseases, and its unique mechanism and clinical value have been highly recognized by our partners.” Chen Yuqing, Chairman of Fosun Pharma said, “By working together with Expedition, the professional teams and rich industry experience of both parties will provide strong support for the global development and commercialization of XH-S004, further expanding the accessibility of this product and enabling global patients to benefit from this innovative therapy as soon as possible.”
“We are pleased to be working with Fosun Pharma, one of the leading pharmaceutical companies in China. XH-S004 is an exciting compound that targets neutrophilic inflammation, an important underlying driver of a number of chronic respiratory diseases.” Yi Larson, Chairman and CEO of Expedition said, “We look forward to partnering with Fosun Pharma in the development of XH-S004 for COPD and other neutrophilic inflammatory diseases to address the significant unmet medical need.”
About Fosun Pharma
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”; SSE: 600196, HKEX: 02196) is a leading innovation-driven global healthcare company operating in the fields of pharmaceuticals, medical devices & diagnostics, and healthcare services. Through its strategic alliance with Sinopharm Group Co., Ltd., Fosun Pharma further extends its capabilities in pharmaceutical commerce.
Over the past 30 years since its establishment, Fosun Pharma has maintained deep roots in China while strategically expanding its global presence. The company has been actively implementing its “4IN” strategy – Innovation, Internationalization, Intelligentization, and Integration, with core business operations now spanning major overseas markets including the United States, Europe, Africa, India, and Southeast Asia. At present, Fosun Pharma has established an open and globally integrated pharmaceutical R&D ecosystem, focusing on core therapeutic areas including oncology (solid tumors and hematologic malignancies) and Immune-inflammatory disorders. The company is strategically enhancing its technological leadership in antibody/ADC platforms, cell therapies, and small molecule development, while collaborating with industry funds to pioneer next-generation modalities such as radiopharmaceuticals, RNA therapeutics, gene editing, and AI-powered drug discovery. This multidimensional approach accelerates the translation of innovative therapies into clinical practice, systematically addressing critical unmet medical needs worldwide.
Looking ahead, Fosun Pharma remains anchored in its core values of “Care for life, Continuous innovation, Pursuit of excellence, and Sustainable partnership”. By advancing its global innovation engine and operational excellence, the company strives to be a global leader to integrate pharmaceutical and healthcare innovations, creating better health for families worldwide.
About Expedition
Expedition Therapeutics was incorporated in Delaware in March 2024. It is a biotechnology company specializing in the research and development of innovative therapies for autoimmune diseases with a core management team of experienced professionals with deep expertise in multinational pharmaceutical and biotechnology companies R&D, business development and operational excellence. Expedition’s current investors include several well-known investment institutions in the United States with extensive industry investment experience.
MyRepublic Completes Sale of Remaining 49.9% Stake in Broadband Business to StarHub
SINGAPORE – Media OutReach Newswire – 12 August 2025 – MyRepublic today announced that StarHub has acquired the remaining 49.9% stake in MyRepublic’s flagship broadband business. From today, StarHub has full ownership of the broadband business.
The two companies began their partnership in 2021, with StarHub acquiring a 50.1% stake for an initial consideration of S$70.8 million.
Over the past four years, this collaboration has combined StarHub’s scale and resources with MyRepublic’s innovation DNA and customer-first approach, driving steady growth in market share and profitability in the broadband division.
“MyRepublic has always sought to push the boundaries of what’s possible in connectivity,” said Malcolm Rodrigues, Founder & CEO of MyRepublic . “As a premium broadband provider especially popular with gamers and customers who care deeply about speed and reliability, we were the first to launch 1Gbps residential broadband in 2014, helping Singapore become a ‘Gig-Nation’. Together with StarHub and with the support of IMDA’s NBN 2.0 initiative, we were again first in bringing nationwide 10Gbps to market.”
With effect from today, StarHub has purchased the remaining 49.9% stake, together with certain other complementary parts of MyRepublic’s business, for a consideration of S$105.2 million.
Rodrigues added “I want to thank MyRepublic customers, employees, partners, regulators, and investors for the opportunity to build this business. Together we’ve reimagined telecom in Singapore and the region.”
“StarHub shares the same customer obsession that has always driven MyRepublic, and our combined vision over the past four years has been a powerful force in delivering this success, and we are safe in the knowledge that the MyRepublic team will continue to deliver innovation and excitement to Singapore’s broadband consumers under StarHub’s stewardship”, said Rodrigues.
The other operations and business of the company, mobile businesses in Singapore and New Zealand, under the MyRepublic and Rocket Mobile brands respectively, as well as its platform and digital business, MyRepublic Digital, will continue as usual. The non-broadband customers can be rest assured that they will continue to enjoy MyRepublic services which will only continue to improve.
Hashtag: #StarHub #MyRepublic #Broadband #GigNation
https://myrepublic.net/sg/
https://www.linkedin.com/company/myrepublic
https://x.com/myrepublic
https://www.facebook.com/MyRepublicSG/
https://www.instagram.com/myrepublicsg/
The issuer is solely responsible for the content of this announcement.
MyRepublic Broadband Pte Ltd
Founded in Singapore in 2011, MyRepublic is a telecommunications company primarily known for providing high speed broadband and mobile services. Headquartered in Singapore, it operates in Singapore and New Zealand and licences its platform to an operator in Brunei. MyRepublic focuses on offering competitive packages to both consumers and businesses, with a strong emphasis on digital transformation within the telecom sector. premium broadband provider known for speed, reliability, and customer-first innovation, serving residential and business customers in Singapore.
eefit Returns to the International Academic Stage — Patented Far Infrared Technology Praised by Nobel Laureate and Renowned Scientists
HONG KONG SAR – Media OutReach Newswire – 12 August 2025 – With a rapidly increasing aging population, chronic non-communicable diseases and sub-health problems faced by middle-aged and elderly people have become even more prominent. Modern medicine has standardised our current diagnosis and treatment system, especially in the intervention of acute symptoms and pathological control. However, in the face of health needs such as long-term management of chronic diseases and conditioning of sub-health problems, which require a “holistic view” and “continuous repair”, its limitations in areas such as healthcare, functional restoration, and improvement of quality of life are gradually becoming apparent.
In the context of improving the lifestyle and functional regulation of middle-aged and elderly people, we seek to help improve their health in a gentle and sustainable manner by exploring new health protection paths outside of traditional medicine.
“The 9th Young Scholars Conference on Ion Channels and Receptors & Forum on Biophysics and Innovative Drug Discovery” was held in June 2025. As a leading energy healthcare technology company, “eefit” became the focus of the event, revealing to the world the innovative application of their patented far infrared technology in healthcare, with results verified by internationally renowned academics and authorities. The benefit provides systematic health management solutions for the middle-aged and elderly population through non-invasive and non-drug methods, creating a new chapter in health technology.
Recognized by Nobel Laureate and Renowned Scientists, eefit Far Infrared Technology is Acclaimed by International Authorities
Organized by the Macau University of Science and Technology (M.U.S.T.), this forum brought together experts in various disciplines from around the world, including neuroscientists and biophysicists. In attendance was 1991 Nobel Laureate in Physiology or Medicine Dr. Erwin Neher, who attended the event as the keynote speaker. It’s worth noting that eefit has been collaborating closely with “Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery” since 2021, promoting transformative scientific research in far infrared technology.
On a similar note, Prof. Vincent Wong of M.U.S.T. (among the top 2% of scientists in the world) introduced the significant effects of eefit’s patented far infrared technology in improving intestinal microecology, regulating cell immunity, and alleviating symptoms of rheumatoid arthritis. His team’s latest research has confirmed that this technology not only can enhance cerebral blood flow and reduce brain damage in patients with ischemic stroke but can also provide an innovative solution for rehabilitation treatment.
Far Infrared Technology is Changing Our Lives
eefit Has Constructed an All-encompassing “Prevention + Maintenance + Restoration” Health Management System
The middle-aged and elderly population is plagued by health issues, such as chronic pain, sleep disorders, immune system disorders, and Alzheimer’s disease. eefit provides comprehensive solutions to address these issues through developing innovative healthcare products. At the forum, experts gathered at the booth set up by eefit to experience firsthand how technology redefines the health management of the elderly.
Case 1: Disease prevention – protecting brain health at the source
eefit’s patented technology reduces the risk of Alzheimer’s disease by reducing Aβ deposits and abnormal tau proteins. The latest research paper presented on-site showed that eefit far infrared energy can penetrate the blood-brain barrier, intervene in pathological protein aggregation, and build a strong line of defense for brain health.
Case 2: Brain healthcare – improving stroke sequelae and neurological function
For patients suffering from sequelae of stroke, eefit Luminous Energy Helmet and Meridian Pro Illuminator can promote microcirculation in the head and improve cerebral blood flow. The research conducted by the research team of Prof. Vincent Wong has confirmed that this technology can reduce stroke sequelae symptoms and dizziness. An expert user at the forum excitedly shared his feedback, “I am a loyal fan of eefit products. I wear the Luminous Energy Helmet for 20 minutes daily. After one month, I find my memory improved, and I don’t get dizzy as often.”
Case 3: Chronic pain management – quick relief for joint and muscle pain
In the field of pain management, products like EEFit Lite can accurately irradiate pain points and inhibit the release of inflammatory factors. Experts verified that “10 minutes of irradiation can reduce knee pain on a pain scale from 6 to 3, with effects lasting for more than 2 hours”.
Case 4: Sleep quality – natural relief for nervous system
eefit far infrared technology can relieve insomnia by regulating nervous system functions. eefit data shows that after daily use for 2 weeks, over 80% of users experienced a 50% reduction in the time they took to fall asleep, as well as an increased duration of deep sleep.
Case 5: Digestive system repair – two-way regulation of intestinal microecology
eefit far infrared energy achieves two-way regulation of gut microbiota in an innovative manner by inhibiting the excessive proliferation of pathogens while promoting the growth of beneficial bacteria and regulating the imbalance of intestinal microecology. Experimental data shows that after two weeks of intervention, the alpha diversity of gut microbiota (Chao1 index) increased by 30%, and abdominal bloating decreased by 45%.
Nobel Laureate Dr. Neher and Prof. Vincent Wong expressed that the eefit technology system demonstrates innovation and practicality at the international forefront, establishing a new model for the health management of the elderly.
Integrating Industry, Academia and Research: Innovative Paths Leading Industry Development
eefit first introduced far infrared technology into health management through independent technology R&D and commercialization execution, which then attracted collaboration with reputable scientific research institutions. This closed-loop ecosystem of “Demand-Driven Innovation” demonstrates benefit’s ability to focus on the core benefits of products by starting from users’ pain points then feeding back technological improvements into scientific research.
At the forum banquet, eefit’s Founder and Chairman Prof. Nick Wang remarked, “We are honoured, looking back on our eight-year partnership between eefit and the research laboratory. This period of collaboration with deep integration of industry, academia and research has not only pioneered groundbreaking research but also produced fruitful scientific and technological achievements.” He emphasized that eefit has always been “user demand-oriented” at its core, by first verifying the value of technology through market research and then extending the application boundaries with the help of prominent scientific researchers to achieve a seamless connection “from lab to real life”.
The Future is Here: eefit’s Multi-dimensional Layout is Leading a New Era of Far Infrared Healthcare Technology
eefit’s future development focuses on three strategic directions: In terms of scaling technological capabilities, they will continue to increase their investment on R&D and explore new boundaries of far infrared technology applications in more areas that impact human health; In terms of advancing global collaboration, they will strengthen partnerships with notable international scientific research institutions and accelerate the process of global adoption; In the field of inclusive health accessibility, they will popularize home healthcare solutions through verified consumer-level healthcare products such as EEFit Lite, Chi Vitaliser, and Luminous Energy Helmet; and they will continue to pioneer the extension of far infrared technology in the field of health supplements, building an all-encompassing health management system of “External healthcare devices + Internal balancing nutrition”.
As a leading energy healthcare technology company in Hong Kong, eefit’s all-encompassing health management system has been universally recognized by respected international scientists. Leveraging their pioneering edge in commercialisation and the ability to transform based on scientific research, eefit will continue to spearhead global innovation of far infrared healthcare technology, ensuring the benefits of science-backed wellness reach everyone.
Hashtag: #eefit
https://www.eefit.com/
https://www.facebook.com/eefit
The issuer is solely responsible for the content of this announcement.
About “The 9th Young Scholars Conference on Ion Channels and Receptors & Forum on Biophysics and Innovative Drug Discovery”
This forum was jointly organized by the Branch of Ion Channels & Receptors, Chinese Neuroscience Society, and Macau University of Science and Technology (M.U.S.T.). It is an important academic event in China focusing on the field of ion channels and receptors. This forum has been held for eight consecutive years and is an important platform for promoting cutting-edge research, innovative drug development and cooperation, and international academic exchanges.
